{"nct_id":"NCT03562871","title":"IO102 With Pembrolizumab, With or Without Chemotherapy, as First-line Treatment of Metastatic NSCLC","status":"COMPLETED","status_verified_date":"2022-04","start_date":"2018-08-22","start_date_type":"ACTUAL","primary_completion_date":"2021-02-06","primary_completion_date_type":"ACTUAL","completion_date":"2022-04-12","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["IOBT"]}